23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Nordic
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement
Share page
Sponsored content

Networking event in Denmark: Sponsor Oversight in Clinical Trials

We are excited to invite clinical trial professionals to a networking event to connect and discuss best practices, challenges and adaptive strategies in documentation of sponsor oversight.

How do we best manage and document our sponsor oversight in documentation of clinical trials? And how should we adopt to ICH-GCP E6 (R3)?

This informal yet insightful gathering will include a short introduction by Anna-Karin Abelson, Clinical Research Manager and Anna Asplind, Senior Clinical Project Managers at PharmaRelations, followed by small-group roundtable discussions.

Light refreshments will be served.

📅 Date: May 6th, 2026
🕓 Time: 15:00 – 17:00
📍 Location: PharmaRelations office at Hummeltoftevej 49, Virum, Denmark

Program Highlights:

15.00 Networking
15.30 Presentation: Updates and reflections on the regulatory expectations for sponsor oversight (ICH-GCP E6(R3),
FDA, EMA updates)
15.50 Roundtable Discussions: Sponsor Oversight documentation – key challenges, strategies & solutions
16.20 Summary of the discussions and key take aways

Register to the event

Let’s exchange ideas, strengthen connections, and elevate sponsor oversight in clinical research!

Reach out to: Anna-Karin Abelson at anna-karin.abelson@pharmarelations.se
for more information.

Seats are limited – please register by 2026-05-01 to secure your spot.
The event is free to attend and open to all registered participants.

We look forward to a meaningful and engaging afternoon together!

PharmaRelations AB
Frösundaviks allé 1
169 70 Solna
Solna stad
Sweden
VAT Number: SE5565447983

Contact Person

Therese Tullgren
Group Marketing Lead
+46 8 165 22 56 therese.tullgren@pharmarelations.se
Advertisement Advertisement
BREAKING
{{ article.headline }}
0.094|instance-web04